Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2012, Article ID 323784, 11 pages
http://dx.doi.org/10.1155/2012/323784
Research Article

Reversal of the Caspase-Dependent Apoptotic Cytotoxicity Pathway by Taurine from Lycium barbarum (Goji Berry) in Human Retinal Pigment Epithelial Cells: Potential Benefit in Diabetic Retinopathy

Herbal Medicine Group, Faculty of Pharmacy, The University of Sydney, Sydney, NSW 2006, Australia

Received 14 December 2011; Accepted 29 January 2012

Academic Editor: I-Min Liu

Copyright © 2012 M. K. Song et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. S. Fong, L. P. Aiello, F. L. Ferris, and R. Klein, “Diabetic retinopathy,” Diabetes Care, vol. 27, no. 10, pp. 2540–2553, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Decanini, P. R. Karunadharma, C. L. Nordgaard, X. Feng, T. W. Olsen, and D. A. Ferrington, “Human retinal pigment epithelium proteome changes in early diabetes,” Diabetologia, vol. 51, no. 6, pp. 1051–1061, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. J. C. S. Yam and A. K. H. Kwok, “Update on the treatment of diabetic retinopathy,” Hong Kong Medical Journal, vol. 13, no. 1, pp. 46–60, 2007. View at Google Scholar · View at Scopus
  4. E. C. Leal, C. A. Aveleira, A. F. Castilho et al., “High glucose and oxidative/nitrosative stress conditions induce apoptosis in retinal endothelial cells by a caspase-independent pathway,” Experimental Eye Research, vol. 88, no. 5, pp. 983–991, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. R. A. Kowluru and S. Odenbach, “Effect of long-term administration of α-lipoic acid on retinal capillary cell death and the development of retinopathy in diabetic rats,” Diabetes, vol. 53, no. 12, pp. 3233–3238, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. A. J. Barber, T. W. Gardner, and S. F. Abcouwer, “The significance of vascular and neural apoptosis to the pathology of diabetic retinopathy,” Investigative Ophthalmology and Visual Science, vol. 52, no. 2, pp. 1156–1163, 2011. View at Publisher · View at Google Scholar
  7. M. K. Song, B. D. Roufogalis, and T. H.W. Huang, “Modulation of diabetic retinopathy pathophysiology by natural medicines through PPAR-γ-related pharmacology,” British Journal of Pharmacology, vol. 165, no. 1, pp. 4–19, 2012. View at Publisher · View at Google Scholar
  8. L. J. Rizzolo, “Polarity and the development of the outer blood-retinal barrier,” Histology and Histopathology, vol. 12, no. 4, pp. 1057–1067, 1997. View at Google Scholar · View at Scopus
  9. S. Beatty, H. H. Koh, M. Phil, D. Henson, and M. Boulton, “The role of oxidative stress in the pathogenesis of age-related macular degeneration,” Survey of Ophthalmology, vol. 45, no. 2, pp. 115–134, 2000. View at Publisher · View at Google Scholar · View at Scopus
  10. R. Roduit and D. F. Schorderet, “MAP kinase pathways in UV-induced apoptosis of retinal pigment epithelium ARPE19 cells,” Apoptosis, vol. 13, no. 3, pp. 343–353, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. J. H. Kim, J. H. Kim, H. O. Jun et al., “Protective effect of clusterin from oxidative stress-induced apoptosis in human retinal pigment epithelial cells,” Investigative Ophthalmology & Visual Science, vol. 51, no. 1, pp. 561–566, 2010. View at Google Scholar · View at Scopus
  12. Y. Yanagi, “Role of peoxisome proliferator activator receptor γ on blood retinal barrier breakdown,” PPAR Research, Article ID 679237, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. S. T. Knudsen, T. Bek, P. L. Poulsen, M. N. Hove, M. Rehling, and C. E. Mogensen, “Macular edema reflects generalized vascular hyperpermeability in type 2 diabetic patients with retinopathy,” Diabetes Care, vol. 25, no. 12, pp. 2328–2334, 2002. View at Google Scholar · View at Scopus
  14. D. A. Allen, M. M. Yaqoob, and S. M. Harwood, “Mechanisms of high glucose-induced apoptosis and its relationship to diabetic complications,” Journal of Nutritional Biochemistry, vol. 16, no. 12, pp. 705–713, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Jeong, T. Kim, H. Park et al., “Taurine exerts neuroprotective effects via anti-apoptosis in hypoxic-ischemic brain injury in neonatal rats,” Korean Journal of Pediatrics, vol. 52, no. 12, pp. 1337–1347, 2009. View at Publisher · View at Google Scholar
  16. T. S. Kern, J. Tang, M. Mizutani et al., “Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia,” Investigative Ophthalmology and Visual Science, vol. 41, no. 12, pp. 3972–3978, 2000. View at Google Scholar · View at Scopus
  17. J. S. Wu, T. N. Lin, and K. K. Wu, “Rosiglitazone and PPAR-γ overexpression protect mitochondrial membrane potential and prevent apoptosis by upregulating anti-apoptotic Bcl-2 family proteins,” Journal of Cellular Physiology, vol. 220, no. 1, pp. 58–71, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Ren, C. Sun, Y. Sun et al., “PPAR γ protects cardiomyocytes against oxidative stress and apoptosis via Bcl-2 upregulation,” Vascular Pharmacology, vol. 51, no. 2-3, pp. 169–174, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. G. A. Rodrigues, F. Maurier-Mahe, D.-L. Shurland et al., “Differential effects of PPARγ ligands on oxidative stress-induced death of retinal pigmented epithelial cells,” Investigative Ophthalmology and Visual Science, vol. 52, no. 2, pp. 890–903, 2011. View at Publisher · View at Google Scholar
  20. J. Y. Chang, P. S. Bora, and N. S. Bora, “Prevention of oxidative stress-induced retinal pigment epithelial cell death by the PPARγ agonists, 15-deoxy-delta 12, 14-prostaglandin J 2,” PPAR Research, Article ID 720163, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Zhao, A. Alexeev, E. Chang, G. Greenburg, and K. Bojanowski, “Lycium barbarum glycoconjugates: effect on human skin and cultured dermal fibroblasts,” Phytomedicine, vol. 12, no. 1-2, pp. 131–137, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. C. Y. Cheng, W. Y. Chung, Y. T. Szeto, and I. F. F. Benzie, “Fasting plasma zeaxanthin response to Fructus barbarum L. (wolfberry; Kei Tze) in a food-based human supplementation trial,” British Journal of Nutrition, vol. 93, no. 1, pp. 123–130, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. Q. Wang, “The present situation of TCM treatment for diabetes and its researches,” Journal of Traditional Chinese Medicine, vol. 23, no. 1, pp. 67–73, 2003. View at Google Scholar · View at Scopus
  24. H. Xie and S. Zhang, “Determination of taurine in Lycium barbarum L. by high performance liquid chromatography with OPA-urea pre-column derivatization,” Se Pu, vol. 15, no. 1, pp. 54–56, 1997. View at Google Scholar · View at Scopus
  25. Y. Cao, X. Zhang, Q. Chu, Y. Fang, and J. Ye, “Determination of taurine in Lycium barbarum L. and other foods by capillary electrophoresis with electrochemical detection,” Electroanalysis, vol. 15, no. 10, pp. 898–902, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. X. Yu, Z. Xu, M. Mi et al., “Dietary taurine supplementation ameliorates diabetic retinopathy via anti-excitotoxicity of glutamate in streptozotocin-induced sprague-dawley rats,” Neurochemical Research, vol. 33, no. 3, pp. 500–507, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Takatani, K. Takahashi, Y. Uozumi et al., “Taurine prevents the ischemia-induced apoptosis in cultured neonatal rat cardiomyocytes through Akt/caspase-9 pathway,” Biochemical and Biophysical Research Communications, vol. 316, no. 2, pp. 484–489, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. Q. Di Wu, J. H. Wang, F. Fennessy, H. P. Redmond, and D. Bouchier-Hayes, “Taurine prevents high-glucose-induced human vascular endothelial cell apoptosis,” American Journal of Physiology, vol. 277, no. 6, pp. C1229–C1238, 1999. View at Google Scholar · View at Scopus
  29. M. K. Song, N. K. Salam, B. D. Roufogalis, and T. H. W. Huang, “Lycium barbarum (Goji Berry) extracts and its taurine component inhibit PPAR-γ-dependent gene transcription in human retinal pigment epithelial cells: possible implications for diabetic retinopathy treatment,” Biochemical Pharmacology, vol. 82, no. 9, pp. 1209–1218, 2011. View at Publisher · View at Google Scholar
  30. M. Ganzera, J. Zhao, and I. A. Khan, “Analysis of terpenelactones in Ginkgo biloba by high performance liquid chromatography and evaporative light scattering detection,” Chemical and Pharmaceutical Bulletin, vol. 49, no. 9, pp. 1170–1173, 2001. View at Publisher · View at Google Scholar · View at Scopus
  31. K. C. Dunn, A. E. Aotaki-Keen, F. R. Putkey, and L. M. Hjelmeland, “ARPE-19, a human retinal pigment epithelial cell line with differentiated properties,” Experimental Eye Research, vol. 62, no. 2, pp. 155–169, 1996. View at Publisher · View at Google Scholar · View at Scopus
  32. T. Yokoyama, K. Yamane, A. Minamoto et al., “High glucose concentration induces elevated expression of anti-oxidant and proteolytic enzymes in cultured human retinal pigment epithelial cells,” Experimental Eye Research, vol. 83, no. 3, pp. 602–609, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. H. S. Chung, M. Kang, C. Cho et al., “Inhibition of nitric oxide and tumor necrosis factor-α by moutan cortex in activated mouse peritoneal macrophages,” Biological and Pharmaceutical Bulletin, vol. 30, no. 5, pp. 912–916, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. P. M. K. Tang, J. Y. W. Chan, S. W. N. Au et al., “Pheophorbide a, an active compound isolated from Scutellaria barbata, possesses photodynamic activities by inducing apoptosis in human hepatocellular carcinoma,” Cancer Biology and Therapy, vol. 5, no. 9, pp. 1111–1116, 2006. View at Google Scholar · View at Scopus
  35. H. T. Hassoun, M. L. Lie, D. N. Grigoryev, M. Liu, R. M. Tuder, and H. Rabb, “Kidney ischemia-reperfusion injury induces caspase-dependent pulmonary apoptosis,” American Journal of Physiology, vol. 297, no. 1, pp. F125–F137, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. G. F. Davies, P. J. Mcfie, R. L. Khandelwal, and W. J. Roesler, “Unique ability of troglitazone to up-regulate peroxisome proliferator-activated receptor-γ expression in hepatocytes,” Journal of Pharmacology and Experimental Therapeutics, vol. 300, no. 1, pp. 72–77, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. C. J. Kennedy, P. E. Rakoczy, and I. J. Constable, “Lipofuscin of the retinal pigment epithelium: a review,” Eye, vol. 9, no. 6, pp. 763–771, 1995. View at Google Scholar · View at Scopus
  38. I. Vermes, C. Haanen, and C. Reutelingsperger, “Flow cytometry of apoptotic cell death,” Journal of Immunological Methods, vol. 243, no. 1-2, pp. 167–190, 2000. View at Publisher · View at Google Scholar · View at Scopus
  39. T. K. Ali and A. B. El-Remessy, “Diabetic retinopathy: current management and experimental therapeutic targets,” Pharmacotherapy, vol. 29, no. 2, pp. 182–192, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. R. A. Kowluru, L. Atasi, and Y. S. Ho, “Role of mitochondrial superoxide dismutase in the development of diabetic retinopathy,” Investigative Ophthalmology and Visual Science, vol. 47, no. 4, pp. 1594–1599, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Patz, “Clinical and experimental studies on retinal neovascularization. XXXIX Edward Jackson memorial lecture,” American Journal of Ophthalmology, vol. 94, no. 6, pp. 715–743, 1982. View at Google Scholar · View at Scopus
  42. R. A. Kowluru, “Diabetic retinopathy: mitochondrial dysfunction and retinal capillary cell death,” Antioxidants and Redox Signaling, vol. 7, no. 11-12, pp. 1581–1587, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. R. Simo, M. Villarroel, L. Corraliza, C. Hernandez, and M. Garcia-Ramirez, “The retinal pigment epithelium: something more than a constituent of the blood-retinal barrier—implications for the pathogenesis of diabetic retinopathy,” Journal of Biomedicine & Biotechnology, vol. 2010, Article ID 190724, 15 pages, 2010. View at Publisher · View at Google Scholar
  44. Y. Aizu, K. Oyanagi, J. Hu, and H. Nakagawa, “Degeneration of retinal neuronal processes and pigment epithelium in the early stage of the streptozotocin-diabetic rats,” Neuropathology, vol. 22, no. 3, pp. 161–170, 2002. View at Publisher · View at Google Scholar · View at Scopus
  45. A. M. Abu El-Asrar, L. Dralands, L. Missotten, I. A. Al-Jadaan, and K. Geboes, “Expression of apoptosis markers in the retinas of human subjects with diabetes,” Investigative Ophthalmology and Visual Science, vol. 45, no. 8, pp. 2760–2766, 2004. View at Publisher · View at Google Scholar · View at Scopus
  46. W. C. Earnshaw, L. M. Martins, and S. H. Kaufmann, “Mammalian caspases: structure, activation, substrates, and functions during apoptosis,” Annual Review of Biochemistry, vol. 68, pp. 383–424, 1999. View at Publisher · View at Google Scholar · View at Scopus
  47. C. Stadelmann and H. Lassmann, “Detection of apoptosis in tissue sections,” Cell and Tissue Research, vol. 301, no. 1, pp. 19–31, 2000. View at Google Scholar · View at Scopus
  48. A. A. Herzlich, J. Tuo, and C. C. Chan, “Peroxisome proliferator-activated receptor and age-related macular degeneration,” PPAR Research, vol. 2008, Article ID 389507, 11 pages, 2008. View at Publisher · View at Google Scholar · View at Scopus
  49. A. Tawfik, T. Sanders, K. Kahook, S. Akeel, A. Elmarakby, and M. Al-Shabrawey, “Suppression of retinal peroxisome proliferator-activated receptor γ in experimental diabetes and oxygen-induced retinopathy: role of NADPH oxidase,” Investigative Ophthalmology and Visual Science, vol. 50, no. 2, pp. 878–884, 2009. View at Publisher · View at Google Scholar
  50. T. N. Lin, W. M. Cheung, J. S. Wu et al., “15d-prostaglandin J2 protects brain from ischemia-reperfusion injury,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 26, no. 3, pp. 481–487, 2006. View at Publisher · View at Google Scholar · View at Scopus
  51. K. Fuenzalida, R. Quintanilla, P. Ramos et al., “Peroxisome proliferator-activated receptor γ up-regulates the Bcl-2 anti-apoptotic protein in neurons and induces mitochondrial stabilization and protection against oxidative stress and apoptosis,” Journal of Biological Chemistry, vol. 282, no. 51, pp. 37006–37015, 2007. View at Publisher · View at Google Scholar · View at Scopus
  52. F. Doonan, D. M. Wallace, C. O'Driscoll, and T. G. Cotter, “Rosiglitazone acts as a neuroprotectant in retinal cells via up-regulation of sestrin-1 and SOD-2,” Journal of Neurochemistry, vol. 109, no. 2, pp. 631–643, 2009. View at Publisher · View at Google Scholar · View at Scopus
  53. R. C. C. Chang and K. F. So, “Use of anti-aging herbal medicine, Lycium barbarum, against aging-associated diseases. What do we know so far?” Cellular and Molecular Neurobiology, vol. 28, no. 5, pp. 643–652, 2008. View at Publisher · View at Google Scholar · View at Scopus
  54. X. M. Li, Y. L. Ma, and X. J. Liu, “Effect of the Lycium barbarum polysaccharides on age-related oxidative stress in aged mice,” Journal of Ethnopharmacology, vol. 111, no. 3, pp. 504–511, 2007. View at Publisher · View at Google Scholar · View at Scopus
  55. M. S. Yu, S. K. Y. Leung, S. W. Lai et al., “Neuroprotective effects of anti-aging oriental medicine Lycium barbarum against β-amyloid peptide neurotoxicity,” Experimental Gerontology, vol. 40, no. 8-9, pp. 716–727, 2005. View at Publisher · View at Google Scholar · View at Scopus
  56. S.-Y. Li, D. Yang, C.-M. Yeung et al., “Lycium barbarum polysaccharides reduce neuronal damage, blood-retinal barrier disruption and oxidative stress in retinal ischemia/reperfusion injury,” PLoS ONE, vol. 6, no. 1, p. e16380, 2011. View at Publisher · View at Google Scholar
  57. Y. Wang, H. Zhao, X. Sheng, P. E. Gambino, B. Costello, and K. Bojanowski, “Protective effect of Fructus Lycii polysaccharides against time and hyperthermia-induced damage in cultured seminiferous epithelium,” Journal of Ethnopharmacology, vol. 82, no. 2-3, pp. 169–175, 2002. View at Publisher · View at Google Scholar · View at Scopus
  58. S. H. Hansen, “The role of taurine in diabetes and the development of diabetic complications,” Diabetes/Metabolism Research and Reviews, vol. 17, no. 5, pp. 330–346, 2001. View at Publisher · View at Google Scholar · View at Scopus
  59. F. Franconi, A. Loizzo, G. Ghirlanda, and G. Seghieri, “Taurine supplementation and diabetes mellitus,” Current Opinion in Clinical Nutrition and Metabolic Care, vol. 9, no. 1, pp. 32–36, 2006. View at Google Scholar · View at Scopus
  60. F. Franconi, M. A. S. Di Leo, F. Bennardini, and G. Ghirlanda, “Is taurine beneficial in reducing risk factors for diabetes mellitus?” Neurochemical Research, vol. 29, no. 1, pp. 143–150, 2004. View at Publisher · View at Google Scholar · View at Scopus
  61. K. Zeng, H. Xu, M. Mi et al., “Effects of taurine on glial cells apoptosis and taurine transporter expression in retina under diabetic conditions,” Neurochemical Research, vol. 35, no. 10, pp. 1566–1574, 2010. View at Publisher · View at Google Scholar · View at Scopus
  62. K. Chen, Q. Zhang, J. Wang et al., “Taurine protects transformed rat retinal ganglion cells from hypoxia-induced apoptosis by preventing mitochondrial dysfunction,” Brain Research, vol. 1279, pp. 131–138, 2009. View at Publisher · View at Google Scholar